Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
13 December, 2017 22:24 IST
Aurobindo Pharma gets USFDA nod for anti-cough tablets
Source: IRIS | 21 Mar, 2017, 09.14AM
Comments  |  Post Comment

Aurobindo Pharma announced that the company has received final approval from the US Food & Drug Administration (USFDA) to manufacture Guaifenesin and Dextromethorphan Hydrobromide extended-release tablets, 600/30 mg and 1200/60mg (OTC). Aurobindo's Guaifenesin and Dextromethorphan Hydrobromide extended-release tablets are the AB rated generic equivalent of Reckitt Benckiser's Mucinex DM tablets. The product will be launched in Q1FY18.

Guaifenesin and Dextromethorphan Hydrobromide extended-release tablets helps loosen mucus and phlegm, and thin out bronchial secretions, making coughs more productive. The approved product has an estimated market size of US$ 235 million for the twelve months ending December 2016 according to IRI database.

This is the 106 th ANDA (including 21 tentative approvals) approved out of Unit VII formulation facility in Hyderabad, India used for manufacturing oral products. Aurobindo now has a total of 311 ANDA approvals (272 Final approvals including 16 from Aurolife Pharma LLC and 39 tentative approvals) from USFDA.

Shares of the company gained Rs 1.7, or 0.24%, to trade at Rs 704.90. The total volume of shares traded was 0 at the BSE (9.01 a.m., Tuesday).



Aurobindo Pharma Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
Bharti Airtel sells 20% stake in DTH arm to Warburg Pincus - 13-Dec-2017 11:24
Seamec enters into contract with Dolphin Offshore for 'SEAMEC III' - 13-Dec-2017 11:13
Asian Paints acquires 100% stake in Reno for Rs 1.59 bn - 13-Dec-2017 10:18
Punj Lloyd wins orders worth Rs 14.53 bn from GAIL, NHAI - 13-Dec-2017 10:14
JB Chemicals receives USFDA nod for Atenolol tablets - 13-Dec-2017 10:08
Kalpataru Power bags new orders worth Rs 8.75 bn - 13-Dec-2017 10:05
Ramco Systems wins order from SUEZ Middle East Water Services - 12-Dec-2017 15:22
BHEL commissions coal-fired power project in Indonesia - 12-Dec-2017 15:14
Alembic Pharma gets USFDA's nod for Darifenacin tablets - 12-Dec-2017 11:58
Infosys features as leader in software testing in NelsonHall report - 12-Dec-2017 10:03
Fiberweb India bags export orders worth Rs 152 mn - 12-Dec-2017 10:00
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer